CN109521202A - A kind of low abundance proteins absolute quantification method based on digital immuno analytical method - Google Patents

A kind of low abundance proteins absolute quantification method based on digital immuno analytical method Download PDF

Info

Publication number
CN109521202A
CN109521202A CN201811282815.8A CN201811282815A CN109521202A CN 109521202 A CN109521202 A CN 109521202A CN 201811282815 A CN201811282815 A CN 201811282815A CN 109521202 A CN109521202 A CN 109521202A
Authority
CN
China
Prior art keywords
particle
detection
absolute quantification
fluidic
micro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811282815.8A
Other languages
Chinese (zh)
Inventor
张清泉
盖宏伟
张雪冰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Normal University
Original Assignee
Jiangsu Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Normal University filed Critical Jiangsu Normal University
Priority to CN201811282815.8A priority Critical patent/CN109521202A/en
Publication of CN109521202A publication Critical patent/CN109521202A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Abstract

The present invention relates to a kind of low abundance proteins absolute quantification methods based on digital immuno analytical method, this method will capture magnetic bead, target antigen and detection particle are immunoreacted, form immune complex, by the detection particle elution in immune complex, collect concentrate eluant, concentrate is transferred to micro-fluidic grain count chip, detection particle deposition is fixed on micro-fluidic grain count chip after solvent volatilization completely in solution to be concentrated, record by imaging is carried out to all detection particles being fixed on micro-fluidic grain count chip, count the quantity that particle is detected on micro-fluidic grain count chip, obtain the molecular number of target protein.It is an advantage of the invention that can be realized the hypersensitive of disease-associated protein, absolute quantification analysis in clinical sample, standard items are not needed, do not need to draw standard curve, with applied widely, detection sensitivity is high, and analysis result accuracy is high, precision is good, the high advantage of flux.

Description

A kind of low abundance proteins absolute quantification method based on digital immuno analytical method
Technical field
The present invention relates to a kind of low abundance proteins absolute quantification method based on digital immuno analytical method, especially one Kind belongs to protein hypersensitive analytical technology neck for the hypersensitive absolute quantification analysis method of low-abundance protein in clinical sample Domain.
Background technique
It is reported that the generation of disease, the unconventionality expression of development and protein or specific protein expression are closely related.It is accurate to survey Determine the content of disease related protein infectious disease prevention and control, screening for cancer and precisely in terms of be of great significance.Currently, egg The quantitative method of white matter mainly includes relative quantification and absolute quantitation.The former is the method based on standard curve, is widely used in Analytical chemistry and clinical examination;The latter does not need protein standard substance, does not need to draw standard curve, is conducive to Simplified analysis step Suddenly, reduce sample preparation and analysis time, increase detection precision.
Isotopic dilution analysis based on mass spectrum (MS) is considered as the mainstream technology of protein absolute quantitation.Analyze it Before, the internal standard compound of isotope labelling is added into appropriate amount of sample, by comparing the internal standard compound of isotope labelling and specific natural The signal difference that peptide fragment generates realizes quantifying for protein.Strictly speaking, belonged to based on mass spectrographic protein absolute quantitation interior The One point standard of mark method.In addition, the sample pretreatment time of mass spectral analysis is long (such as isotope labelling, trypsin digestion), Instrument precision is expensive, cannot be quantitative to low abundance proteins, limits it in the application of hypersensitive analysis field.
Numerical analysis technique is a kind of potential biomolecule absolute quantification method.Sample is scattered in multiple short spaces (such as micropore and microlayer model), single short space contain the quantity of biomolecule less than 6.The signal of short space output is used " 1 " and " 0 " indicate, respectively represent target molecule with and without.Using Poisson distribution as statistical basis, the concentration of target molecule can be by The ratio of " 1 ", which calculates, to be obtained.According to above-mentioned theory, digital drop PCR(polymerase chain reaction) technology has been carried out nucleic acid Absolute copy number analysis.But existing protein numerical analysis technique (Enzyme Linked Immunoadsorbent Assay and digital electrochemical analysis) It is lost part signal in signal amplification and departure process, still needs to antigen standard and standard curve to realize that protein is fixed Amount.Therefore, it is necessary to develop new digital immunoassay strategy or method of counting to realize protein absolute quantitation.
Summary of the invention
It is an object of the invention to: in view of the deficiency of the prior art, propose a kind of based on digital immunoassay The low abundance proteins absolute quantification method of technology, be able to solve existing protein analysis technology can not absolute quantitation the problem of, Technological gap is filled up.
In order to reach the goals above, technical scheme is as follows: a kind of based on the low rich of digital immuno analytical method Protein absolute quantification method is spent, for the system that this method is related to using optical microscopy as imaging platform, micro-fluidic chip is particle Counting device, number are immunized as analytical model, and micron particles are count detection probe, can realize clinical sample in single molecules level Hypersensitive, the absolute quantification analysis of middle low abundance proteins.Method includes the following steps:
The first step, the micron particles that the magnetic bead, target antigen (i.e. target protein) and modification of modification capture antibody are detected to antibody It is immunoreacted, forms ternary immune complex, contain a target protein molecule in an immune complex;Modification capture The magnetic bead of antibody referred to as capture magnetic bead, the micron particles of modification detection antibody referred to as detection particle;
Second step is eluted the detection particle in ternary immune complex using acid solution, is collected and is concentrated comprising inspection Survey the eluent of particle;
The detection particle solution of concentration is transferred to micro-fluidic grain count chip, solvent evaporation method fixed test by third step , the completely rear detection particle of solvent volatilization, which deposits, in solution to be concentrated is fixed on micro-fluidic grain count chip, then uses optics Microscope carries out record by imaging to all detection particles being fixed on micro-fluidic grain count chip;
The quantity of particle is detected in 4th step, the micro-fluidic grain count chip of statistics to get the molecular number of target protein is arrived.
Absolute quantitation range of the present invention be 180~60000 protein molecules, i.e., 3 × 10-18 M~1 × 10-15 M (100 μ L sample).
The technical solution that the present invention advanced optimizes is as follows:
Preferably, in third step, under the substrate surface positioning grid auxiliary of micro-fluidic grain count chip, using optical microphotograph Mirror successively carries out subregion imaging to the detection particle of all fixations, obtains microphoto.
Preferably, in the 4th step, using the detection amounts of particles in software statistics microphoto, as point of target antigen Subnumber.
Preferably, to detect particle as the direct exhausted of the target protein molecule in count detection probe realization individual particle level To quantitative analysis, Monitoring lower-cut is 50 molecules, and dynamic range is 180~60000 molecules.
Preferably, in the first step, previously prepared capture magnetic bead and detection particle are needed, the method for preparation capture magnetic bead is such as Under:
It takes magnetic bead stoste and magnetic bead stoste is cleaned using sodium hydroxide solution and deionized water, add into the magnetic bead stoste after cleaning Enter EDC solution, stand 0.2 ~ 1 hour at room temperature, Magneto separate removes supernatant, and it is anti-that capture is added to the lower part precipitating after Magneto separate Liquid solution, concussion is incubated for 0.5 ~ 2 hour at room temperature, cleans to obtain capture magnetic bead using PBS buffer solution;
The method of preparation detection particle is as follows:
It takes micron particles stoste and uses MES buffer solution for cleaning, EDC solution, room is added into the micron particles stoste after cleaning The lower mixing of temperature 15 minutes, is centrifuged off supernatant, and after using PBS buffer solution cleaning to the lower part precipitating after centrifugation, detection is added Antibody, concussion is incubated for 0.5 ~ 3 hour at room temperature, PBS buffer solution cleaning, and hydroxylamine hydrochloride solution is then added and mixes 30 minutes, obtains To detection particle.
Preferably, in the first step, the specific method is as follows for preparation ternary immune complex:
Capture magnetic bead solution is taken, Magneto separate removes supernatant, and target antigen solution, room temperature is added into the lower part precipitating after Magneto separate After lower concussion is incubated for 0.5 ~ 3 hour, Magneto separate removes supernatant, then confining liquid, room temperature is added into the lower part precipitating after Magneto separate Lower closing 0.5 ~ 1.5 hour, Magneto separate removes supernatant, and detection particle solution, room temperature are then added into the precipitating after Magneto separate Lower concussion is incubated for 0.5 ~ 3 hour, forms ternary immune complex.
Preferably, the shape of the detection particle is spherical shape, star, triangle, stick, annular or irregular shape.
Preferably, the detection particle is by one kind of high molecular material, inorganic material or biomaterial or above-mentioned any two The composite material of kind is made;The size of the detection particle is between 0.5~10 micron.
Preferably, the high molecular material be at least one of polystyrene, silica gel, polyacrylate, epoxy resin, The inorganic material is at least one of inorganic silicon materials, inorganic carbon material, semiconductor material, and the biomaterial is poly- third Acrylamide and its derivative gel, polyethylene glycol gel, peptide-based gel, gelatin, calcium alginate gel, cellulose and its derivates At least one of gel.
Preferably, the optical microscopy is conventional light field microscope, conventional fluorescent microscope or micromation microscope.
Preferably, the micro-fluidic grain count chip is by having the substrate of positioning grid and microporous layers to be bonded.
Preferably, the material of the substrate is glass, polymethyl methacrylate (PMMA), dimethyl silicone polymer (PDMS), polycarbonate (PC), any one in polystyrene (PS);The material of the microporous layers is glass, poly- methyl-prop Any one of e pioic acid methyl ester (PMMA), dimethyl silicone polymer (PDMS), polycarbonate (PC), polystyrene (PS);It is described Positioning grid is lines, figure, any one or a few combination in icon.
It is an advantage of the invention that can be realized the hypersensitive of disease-associated protein, absolute quantification analysis in clinical sample, Standard items are not needed, do not need to draw standard curve, have applied widely, detection sensitivity is high, analysis result accuracy is high, Precision is good, the high advantage of flux.
Detailed description of the invention
The invention will be further described with reference to the accompanying drawing.
Fig. 1 is digital immunoassay flow diagram in the present invention.
Fig. 2 is the schematic diagram of micro-fluidic grain count chip in the present invention.
Fig. 3 is the light field figure of detection particle in chip micropore in the present invention.
Fig. 4 is that the absolute quantity of particle and the corresponding relationship of CEA molecular number are detected in the present invention.
Fig. 5 is the canonical plotting that Plays addition method of the present invention detects #5 plasma C EA.
Fig. 6 is the canonical plotting that Plays addition method of the present invention detects #10 plasma C EA.
In figure: 1. capture magnetic beads, 2. detection particles, 3. antigens, 4. magnet, 5. basal layers with positioning grid, 6. Microporous layers, 7. liquid-transfering guns, 8. detection particle suspension liquids, 9. positioning grid lines, 10. detection particles.
Specific embodiment
Following will be combined with the drawings in the embodiments of the present invention, and technical solution in the embodiment of the present invention carries out clear, complete Site preparation description, it is clear that described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.It is based on Embodiment in the present invention, it is obtained by those of ordinary skill in the art without making creative efforts every other Embodiment shall fall within the protection scope of the present invention.
A kind of low abundance proteins absolute quantification method based on digital immuno analytical method, the system that this method is related to Optical microscopy is imaging platform, and micro-fluidic chip is grain count device, and number is immunized as analytical model, and micron particles are meter Number detection probe, can realize the hypersensitive of low abundance proteins, absolute quantification analysis in clinical sample in single molecules level.The party Method the following steps are included:
The first step, the micron particles that the magnetic bead, target antigen (i.e. target protein) and modification of modification capture antibody are detected to antibody It is immunoreacted, forms ternary immune complex, it is immune that a target antigen molecules generate an immune complex i.e. one Contain a target protein molecule in compound;The magnetic bead of modification capture antibody referred to as capture magnetic bead, modifies the micro- of detection antibody Rice grain referred to as detection particle.
Previously prepared capture magnetic bead and detection particle are needed, the method for preparation capture magnetic bead is as follows:
It takes magnetic bead stoste and magnetic bead stoste is cleaned using sodium hydroxide solution and deionized water, add into the magnetic bead stoste after cleaning Enter EDC solution, stand 0.2 ~ 1 hour at room temperature, Magneto separate removes supernatant, and it is anti-that capture is added to the lower part precipitating after Magneto separate Liquid solution, concussion is incubated for 0.5 ~ 2 hour at room temperature, cleans to obtain capture magnetic bead using PBS buffer solution;
The method of preparation detection particle is as follows:
It takes micron particles stoste and uses MES buffer solution for cleaning, EDC solution, room is added into the micron particles stoste after cleaning The lower mixing of temperature 15 minutes, is centrifuged off supernatant, and after using PBS buffer solution cleaning to the lower part precipitating after centrifugation, detection is added Antibody, concussion is incubated for 0.5 ~ 3 hour at room temperature, PBS buffer solution cleaning, and hydroxylamine hydrochloride solution is then added and mixes 30 minutes, obtains To detection particle.
Preparing ternary immune complex, the specific method is as follows:
Capture magnetic bead solution is taken, Magneto separate removes supernatant, and target antigen solution, room temperature is added into the lower part precipitating after Magneto separate After lower concussion is incubated for 0.5 ~ 3 hour, Magneto separate removes supernatant, then confining liquid, room temperature is added into the lower part precipitating after Magneto separate Lower closing 0.5 ~ 1.5 hour, Magneto separate removes supernatant, and detection particle solution, room temperature are then added into the precipitating after Magneto separate Lower concussion is incubated for 0.5 ~ 3 hour, forms ternary immune complex.
The shape for detecting particle is spherical shape, star, triangle, stick, annular and irregular shape etc..Particle is detected by height Molecular material, one kind of inorganic material or biomaterial or above-mentioned any two kinds of composite material are made;Detect the size of particle Between 0.5~10 micron;The high molecular material is polystyrene, silica gel, polyacrylate, at least one in epoxy resin Kind, the inorganic material is at least one of inorganic silicon materials, inorganic carbon material, semiconductor material, and the biomaterial is Polyacrylamide and its derivative gel, polyethylene glycol gel, peptide-based gel, gelatin, calcium alginate gel, cellulose and its spread out At least one of biogel.
Second step is eluted the detection particle in ternary immune complex using acid solution, collects and packet is concentrated The eluent of the particle containing detection.
The detection particle solution of concentration is transferred to micro-fluidic grain count chip, the fixed inspection of solvent evaporation method by third step Particle is surveyed, detection particle deposition is fixed on micro-fluidic grain count chip after solvent volatilization completely in solution to be concentrated, then is used Optical microscopy carries out record by imaging to all detection particles being fixed on micro-fluidic grain count chip;In micro-fluidic particle Under the substrate surface positioning grid auxiliary of counting chip, successively the detection particle of all fixations is divided using optical microscopy Area's imaging, obtains microphoto.
Optical microscopy is conventional light field microscope, conventional fluorescent microscope or micromation microscope.Micro-fluidic particle meter Number chip is by having the substrate of positioning grid and microporous layers to be bonded.The material of substrate is glass, polymethyl methacrylate (PMMA), dimethyl silicone polymer (PDMS), polycarbonate (PC), any one in polystyrene (PS);The material of microporous layers Matter is glass, polymethyl methacrylate (PMMA), dimethyl silicone polymer (PDMS), polycarbonate (PC), polystyrene (PS) any one.Positioning grid is lines, figure, any one or a few combination in icon.
The quantity of particle is detected in 4th step, the micro-fluidic grain count chip of statistics to get the molecular number of target protein is arrived; Using the detection amounts of particles in software statistics microphoto, the as molecular number of target antigen;Inspection is counted to detect particle Probing needle realizes that the direct absolute quantification analysis of the target protein molecule in individual particle level, Monitoring lower-cut are 50 molecules, moves State range is 180~60000 molecules.
1 CEA(carcinoembryonic antigen of embodiment, carcinomebryonic antigen) standard items absolute quantification analysis
Capture magnetic bead preparation: 100 μ L magnetic beads (2 × 10 are pipetted9A/mL) stoste is in 1mL centrifuge tube, using equivalent 0.01M NaOH solution is cleaned twice, and aliquots of deionized water cleans 3 times, and the 50mg/mL EDC of the 200 fresh configurations of μ L cold water is then added (i.e. 1- (3- dimethylamino-propyl) -3- ethyl-carbodiimide hydrochloride) solution is incubated at room temperature 30 minutes, and Magneto separate removes supernatant After liquid, 60 μ L capture antibody-solutions (antibody mass is 120 μ g) are added and adds 100 μ L after incubation at room temperature 30 minutes and contains The PBS(phosphate buffer saline of 0.1% tween20, phosphate buffered saline solution) buffer (pH=7.4) cleaning 4 It is secondary, capture magnetic bead is finally obtained, 4 DEG C of refrigerators save backup.
Detection particle preparation: 100 μ L particle (100mg/mL) stostes are pipetted into 1mL centrifuge tube, 50mM MES(, that is, 2- (N- morpholine) ethanesulfonic acid) buffer (pH=5) cleaning twice, be diluted to 1mL, add 10mg EDC, room temperature mixes 15 points Clock is centrifuged off supernatant, after 0.5mL PBS buffer solution (pH=7.4) cleaning twice, 0.236 g is added and detects antibody, room temperature is incubated Educate 3h, PBS buffer solution is cleaned twice, is resuspended in 0.5 mL 10mg/mL hydroxylamine hydrochloride solution, is mixed 30 minutes, with containing The PBS buffer solution of 0.1% tween20 is cleaned 2 times, and detection particle is obtained, and 4 DEG C of refrigerators save backup.
Immune response process: 300 μ L capture magnetic bead solution (2 × 10 is pipetted6A/mL) in 1mL centrifuge tube, Magneto separate removes Remove supernatant;100 μ L carcinomebryonic antigen (CEA) standard solution are added, are incubated at room temperature 1 hour, Magneto separate removes supernatant;Then plus Enter 300 μ L confining liquids, room temperature is closed 30 minutes, and Magneto separate removes supernatant;It is eventually adding 100 μ L detection particle solution (1mg/ ML), it is incubated at room temperature 1 hour, forms ternary immune complex, Magneto separate removes supernatant.It is slow using the PBS containing 0.1% tween20 Fliud flushing (pH=7.4) is cleaned ternary immune complex 4 times, and to remove unbonded detection particle, 100 μ L citric acids are then added Buffer (pH=3.1) elutes ternary immune complex 4 times, and the detection particle in ternary immune complex is eluted, magnetic point From the detection particle collected in supernatant, using 200 μ L deionized water eccentric cleaning collection liquid 2 times, about 10 μ L(are concentrated into as schemed 1).
Detection grain count: 3~4 μ L of detection particle solution of above-mentioned elution is pipetted in the micro- of micro-fluidic microballoon counting chip Kong Zhong heats concentrate under the conditions of 90 DEG C and volatilizees completely to solvent, and detection particle is deposited on micropore bottom, repeats above-mentioned mistake Journey, until the detection particle of all elutions is all deposited on micropore bottom (such as Fig. 2).It is added into micro-fluidic microballoon counting chip 3 μ L deionized waters, covered, then in the case where the positioning grid of chip substrate guides, using optical microscopy to fixed It detects particle and carries out subregion imaging (such as Fig. 3), the detection amounts of particles of all microphotos of software statistics, the as molecule of CEA Number.When antigen molecule number changes, the number for detecting particle also changes (such as Fig. 4) therewith
The absolute quantification analysis of 2 plasma C EA of embodiment
CEA standard solution is only replaced with dilution 10 with embodiment 1 by the operating procedure of embodiment 25Human plasma sample again.Blood The molecular number of slurry samples CEA is equal to the quantity of detection particle, and the concentration of CEA is in combination with sample volume and Avgadro constant meter It calculates and obtains, the results are shown in Table 1.Table 1 be in 10 plasma samples the absolute quantification analysis result, hospital's testing result of CEA and The contrast table of Standard entertion analysis result.Wherein, a is dilution 105Blood plasma again, b is whole plasm.
The Standard entertion of 3 plasma C EA of embodiment is analyzed
#5 plasma sample is diluted 105Times, 5 parts of diluted blood plasma (every part of 100 μ L) are taken, 0,5,10,15,20 μ L are separately added into Concentration is the CEA standard solution of 200aM, and the CEA final concentration of addition is respectively 0,10,20,30,40aM, and subsequent process steps are same Embodiment 1, it is only necessary to which CEA standard solution is replaced with to the plasma sample of above-mentioned addition CEA.With the CEA final concentration added in blood plasma For abscissa, the quantity for detecting particle is ordinate, is drawn standard curve (such as Fig. 5).In Fig. 5, the reverse extending of standard curve Line and X-axis are met at a bit, and the abscissa of the intersection point is 37.3, dilution 105#5 plasma sample CEA concentration again is 37.3 aM.#5 blood plasma stoste CEA concentration is 0.57ng/mL.Under the same terms, Standard entertion curve such as Fig. 6 institute of #10 plasma sample Show, #10 blood plasma stoste CEA concentration is 0.67ng/mL.
Table 1

Claims (9)

1. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method, which is characterized in that including following Step:
The micron particles of the magnetic bead of modification capture antibody, target antigen and modification detection antibody are immunoreacted by the first step, Ternary immune complex is formed, an antigen molecule generates an immune complex;The magnetic bead of modification capture antibody referred to as captures Magnetic bead, the micron particles of modification detection antibody referred to as detection particle;
Second step is eluted the detection particle in ternary immune complex using acid solution, is collected and is concentrated comprising inspection Survey the eluent of particle;
The detection particle solution of concentration is transferred to micro-fluidic grain count chip by third step, is detected after solvent volatilization completely Particle deposition is fixed on micro-fluidic grain count chip, then is fixed on micro-fluidic grain count to all using optical microscopy Detection particle on chip carries out record by imaging;
The quantity of particle is detected in 4th step, the micro-fluidic grain count chip of statistics to get the molecular number of target protein is arrived.
2. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 1, It is characterized in that, in third step, under the substrate surface positioning grid auxiliary of micro-fluidic grain count chip, using optical microscopy Subregion imaging successively is carried out to the detection particle of all fixations, obtains microphoto;In 4th step, the inspection in microphoto is counted Survey amounts of particles, the as molecular number of target antigen;To detect particle as the mesh in count detection probe realization individual particle level The direct absolute quantification analysis of protein molecular is marked, Monitoring lower-cut is 50 molecules, and dynamic range is 180~60000 molecules.
3. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 2, It is characterized in that, in the first step, the specific method is as follows for preparation ternary immune complex:
Capture magnetic bead solution is taken, Magneto separate removes supernatant, and target antigen solution, room temperature is added into the lower part precipitating after Magneto separate After lower concussion is incubated for 0.5 ~ 3 hour, Magneto separate removes supernatant, then confining liquid, room temperature is added into the lower part precipitating after Magneto separate Lower closing 0.5 ~ 1.5 hour, Magneto separate removes supernatant, and detection particle solution, room temperature are then added into the precipitating after Magneto separate Lower concussion is incubated for 0.5 ~ 3 hour, forms ternary immune complex.
4. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 3, It is characterized in that, the shape of the detection particle is spherical shape, star, triangle, stick, annular or irregular shape.
5. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 4, It is characterized in that, the detection particle is answered by one kind of high molecular material, inorganic material or biomaterial or above-mentioned any two kinds Condensation material is made;The size of the detection particle is between 0.5~10 micron.
6. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 5, Be characterized in that, the high molecular material be at least one of polystyrene, silica gel, polyacrylate, epoxy resin, it is described Inorganic material is at least one of inorganic silicon materials, inorganic carbon material, semiconductor material, and the biomaterial is polyacrylamide Amine and its derivative gel, polyethylene glycol gel, peptide-based gel, gelatin, calcium alginate gel, cellulose and its derivates gel At least one of.
7. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 6, It is characterized in that, the optical microscopy is conventional light field microscope, conventional fluorescent microscope or micromation microscope.
8. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 7, It is characterized in that, the micro-fluidic grain count chip is by having the substrate of positioning grid and microporous layers to be bonded.
9. a kind of low abundance proteins absolute quantification method based on digital immuno analytical method according to claim 8, It is characterized in that, the material of the substrate is glass, polymethyl methacrylate, dimethyl silicone polymer, polycarbonate, polyphenyl second Any one in alkene;The material of the microporous layers is glass, polymethyl methacrylate, dimethyl silicone polymer, poly- carbonic acid Any one of ester, polystyrene;The grid that positions is any one or a few combination in lines, figure, icon.
CN201811282815.8A 2018-10-31 2018-10-31 A kind of low abundance proteins absolute quantification method based on digital immuno analytical method Pending CN109521202A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811282815.8A CN109521202A (en) 2018-10-31 2018-10-31 A kind of low abundance proteins absolute quantification method based on digital immuno analytical method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811282815.8A CN109521202A (en) 2018-10-31 2018-10-31 A kind of low abundance proteins absolute quantification method based on digital immuno analytical method

Publications (1)

Publication Number Publication Date
CN109521202A true CN109521202A (en) 2019-03-26

Family

ID=65773020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811282815.8A Pending CN109521202A (en) 2018-10-31 2018-10-31 A kind of low abundance proteins absolute quantification method based on digital immuno analytical method

Country Status (1)

Country Link
CN (1) CN109521202A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110031622A (en) * 2019-05-06 2019-07-19 中山大学 A kind of minute yardstick magnetic enrichment detection device and detection method for immunoassay
CN111398137A (en) * 2020-04-02 2020-07-10 华中农业大学 Detection method based on resistance micron-pore particle counter and application thereof
CN112014369A (en) * 2020-08-25 2020-12-01 上海市皮肤病医院 System and method for quickly detecting analyte by using ultrasensitive digital chromatography
CN112816706A (en) * 2021-01-06 2021-05-18 上海理工大学 Digital ELISA system and using method thereof
CN112964868A (en) * 2021-02-05 2021-06-15 华中农业大学 Biochemical analysis method for simultaneously detecting multiple target objects based on magnetic separation
CN112980806A (en) * 2021-02-08 2021-06-18 厦门大学 Virus single particle separation method based on nano-micro composite sphere
CN113049478A (en) * 2021-04-25 2021-06-29 中国计量科学研究院 Protein aggregate analysis and detection device based on micro-fluidic chip and working method
CN113687062A (en) * 2020-05-17 2021-11-23 格物致和生物科技(北京)有限公司 Biological target digitalized quantitative chip detection method based on virtual segmentation method
CN113687061A (en) * 2020-05-17 2021-11-23 格物致和生物科技(北京)有限公司 Biological target digital quantitative detection system based on virtual segmentation method
CN114034791A (en) * 2021-11-09 2022-02-11 谱天(天津)生物科技有限公司 Method for improving identification number of protein andor peptide fragment group mass spectrum by using polystyrene material

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104884605A (en) * 2012-08-24 2015-09-02 耶鲁大学 System, device and method for high-throughput multi-plexed detection
CN108072643A (en) * 2017-12-28 2018-05-25 厦门大学 A kind of target detection method and system based on digital microfluidic technology and Surface enhanced Raman scattering technology

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104884605A (en) * 2012-08-24 2015-09-02 耶鲁大学 System, device and method for high-throughput multi-plexed detection
CN108072643A (en) * 2017-12-28 2018-05-25 厦门大学 A kind of target detection method and system based on digital microfluidic technology and Surface enhanced Raman scattering technology

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JANINE MOK等: "Digital microfluidic assay for protein detection", 《PNAS》 *
LIANG ZHU等: "Digital immunoassay of a prostate-speci fi c antigen using gold nanorods and magnetic nanoparticles", 《RSC ADV》 *
XI WU等: "A universal and enzyme-free immunoassay platform for biomarker detection based on gold nanoparticle enumeration with a dark field microscope", 《ANALYST》 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110031622A (en) * 2019-05-06 2019-07-19 中山大学 A kind of minute yardstick magnetic enrichment detection device and detection method for immunoassay
CN111398137A (en) * 2020-04-02 2020-07-10 华中农业大学 Detection method based on resistance micron-pore particle counter and application thereof
CN113687061B (en) * 2020-05-17 2023-06-20 格物致和生物科技(北京)有限公司 Biological target digital quantitative detection system based on virtual segmentation method
CN113687062A (en) * 2020-05-17 2021-11-23 格物致和生物科技(北京)有限公司 Biological target digitalized quantitative chip detection method based on virtual segmentation method
CN113687061A (en) * 2020-05-17 2021-11-23 格物致和生物科技(北京)有限公司 Biological target digital quantitative detection system based on virtual segmentation method
CN112014369A (en) * 2020-08-25 2020-12-01 上海市皮肤病医院 System and method for quickly detecting analyte by using ultrasensitive digital chromatography
CN112014369B (en) * 2020-08-25 2024-02-09 上海市皮肤病医院 System and method for ultrasensitive digital chromatography rapid detection of analytes
CN112816706A (en) * 2021-01-06 2021-05-18 上海理工大学 Digital ELISA system and using method thereof
CN112816706B (en) * 2021-01-06 2023-08-29 上海理工大学 Digital ELISA system and use method thereof
CN112964868A (en) * 2021-02-05 2021-06-15 华中农业大学 Biochemical analysis method for simultaneously detecting multiple target objects based on magnetic separation
CN112964868B (en) * 2021-02-05 2022-06-28 华中农业大学 Biochemical analysis method for simultaneously detecting multiple target objects based on magnetic separation
CN112980806B (en) * 2021-02-08 2022-09-13 厦门大学 Virus single particle separation method based on nano-micro composite sphere
CN112980806A (en) * 2021-02-08 2021-06-18 厦门大学 Virus single particle separation method based on nano-micro composite sphere
CN113049478B (en) * 2021-04-25 2022-05-17 中国计量科学研究院 Protein aggregate analysis and detection device based on micro-fluidic chip and working method
CN113049478A (en) * 2021-04-25 2021-06-29 中国计量科学研究院 Protein aggregate analysis and detection device based on micro-fluidic chip and working method
CN114034791A (en) * 2021-11-09 2022-02-11 谱天(天津)生物科技有限公司 Method for improving identification number of protein andor peptide fragment group mass spectrum by using polystyrene material

Similar Documents

Publication Publication Date Title
CN109521202A (en) A kind of low abundance proteins absolute quantification method based on digital immuno analytical method
Howard et al. A sample preparation and analysis system for identification of circulating tumor cells
Chia et al. Advances in exosome quantification techniques
JP6553020B2 (en) Automated immunoassay system for performing diagnostic analysis on allergies and autoimmune diseases
US7455980B2 (en) Method for characterizing autoimmune disorders
JPH03504276A (en) Analysis method
CN103033619B (en) A kind of protein chip kit of comprehensive detection lung cancer marker and method
CN106706926A (en) Serum amyloid A testing kit and manufacturing method
US20210088517A1 (en) MULTIPLEX HIGH-THROUGHPUT FLOW CYTOMETRY DETECTION OF SARS-COV-2-SPECIFIC IgG, IgA AND IgM
JP2007101559A (en) Standard diluent for multiplex assay
CN101939648B (en) Immunomagnetic capture and imaging of biological targets
WO1995022766A1 (en) Solid phase assay for detection of ligands
CN110426515B (en) Kit for detecting trace drugs in sewage by time-resolved fluorescence immunochromatographic technique and application thereof
CN101046479B (en) Process of preparing human serum base matter containing no target protein
JP2019215342A (en) Separation method and analysis method for microvesicle from human urine
CN109142753A (en) Squamous cell carcinoma-related antigen chemiluminescence immune detection reagent kit and preparation method thereof
US11486878B2 (en) Compositions and methods for identifying cancer cells
Huang et al. Receptor antibody time‐resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy
CN106771264A (en) Thyrotropin assay kit and preparation method
CN102375063A (en) Immune mass spectrometric kit of common proteins and preparation method thereof
US20050191677A1 (en) Mass spectrometric concentration measurement of proteins
Sunheimer et al. Analysis: principles of instrumentation
US6951716B2 (en) Anti-platelet immunoglobulin bead positive control
RU2717671C1 (en) Method for multiplex immunological analysis of biological samples from air in automatic mode
JP2010078374A (en) Method of detecting anti-erythrocyte antibody

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190326

RJ01 Rejection of invention patent application after publication